2:13   Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy 7:37   Syncona launches new gene therapy company Beacon Therapeutics 1:41   XLRP Gene Therapy Trial Results: What VISTA Actually Showed 4:27   Beacon's emerging XLRP gene therapy improves low-light vision in phase 3 trial 3:10   Family Man and Life-Changing Clinical Trial Participant | Mark Curley | Beacon Story 10:53   Breaking: Beacon's Gene Therapy Laru-zova Hits in XLRP — What the VISTA Data Mean 7:54   Retinitis Pigmentosa Cure 2026: The Scientific Revolution from Gene Editing to Optogenetics 7:07   Retinitis Pigmentosa Cure 2026: The Scientific Revolution from Gene Editing to Optogenetics 1:54   Spinout Spotlights - Robert MacLaren, Professor of Ophthalmology, University of Oxford 12:52   Looking to gene therapy for ocular diseases, with Lance Baldo 2:33   Beacon Targeted Therapies - How We Can Help You with Your Drug Development 11:17   The Repair of Early Trauma: A Bottom Up Approach 6:28   Epic Systems modules | Epic Beacon (Oncology) | 9:10   Your Systemic Anti-Cancer Treatment in the Beacon Centre – Oral Treatment 0:52   Beacon Therapy